TW201306847A - Compositions and uses - Google Patents

Compositions and uses Download PDF

Info

Publication number
TW201306847A
TW201306847A TW100143957A TW100143957A TW201306847A TW 201306847 A TW201306847 A TW 201306847A TW 100143957 A TW100143957 A TW 100143957A TW 100143957 A TW100143957 A TW 100143957A TW 201306847 A TW201306847 A TW 201306847A
Authority
TW
Taiwan
Prior art keywords
compositions
uses
subject
heparin
copd
Prior art date
Application number
TW100143957A
Inventor
Frazer Giles Morgan
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB1020268.7A priority Critical patent/GB201020268D0/en
Priority to GBGB1104632.3A priority patent/GB201104632D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of TW201306847A publication Critical patent/TW201306847A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan

Abstract

According to the invention there is provided heparin for use in the treatment of COPD, wherein, after administration to a subject, the heparin reduces inflammation in the lungs of the subject.
TW100143957A 2010-11-30 2011-11-30 Compositions and uses TW201306847A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1020268.7A GB201020268D0 (en) 2010-11-30 2010-11-30 Composition and uses
GBGB1104632.3A GB201104632D0 (en) 2011-03-18 2011-03-18 Use of medicament

Publications (1)

Publication Number Publication Date
TW201306847A true TW201306847A (en) 2013-02-16

Family

ID=45349232

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100143957A TW201306847A (en) 2010-11-30 2011-11-30 Compositions and uses

Country Status (2)

Country Link
TW (1) TW201306847A (en)
WO (1) WO2012073025A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201611639D0 (en) * 2016-07-04 2016-08-17 Ockham Biotech Ltd Delivery device and formulation
WO2019139479A1 (en) 2018-01-11 2019-07-18 Rob Janssen Compositions and methods for the treatment of lung emphysema and other forms of copd

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
WO1998004133A1 (en) * 1996-07-29 1998-02-05 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
GB2353222B (en) 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
AU2211802A (en) 2000-11-30 2002-06-11 Vectura Ltd Pharmaceutical compositions for inhalation
AT378039T (en) 2000-06-27 2007-11-15 Vectura Ltd Production method of particles for use in a pharmaceutical composition
GB2364919A (en) 2000-07-21 2002-02-13 Cambridge Consultants Inhalers
EP1392382B1 (en) 2001-05-10 2008-08-06 Vectura Delivery Devices Limited Inhaler
EP1511466B2 (en) * 2002-02-18 2015-02-25 Ockham Biotech Limited Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
GB0321607D0 (en) 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
WO2005025535A2 (en) 2003-09-15 2005-03-24 Vectura Limited Methods for preparing pharmaceutical compositions
CA2678587A1 (en) * 2007-02-28 2008-09-04 Paringenix, Inc. O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease
GB0901520D0 (en) 2009-01-30 2009-03-11 Vectura Delivery Devices Ltd Inhaler

Also Published As

Publication number Publication date
WO2012073025A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
JO3199B1 (en) Substituted 5-fluoro-1H-pyrazolopyridines and their use
HUE040211T2 (en) Microbiota restoration therapy (mrt), compositions and methods of manufacture
TW201323424A (en) Compounds
TW201204714A (en) New compounds
EA201390060A1 (en) Anneled pyrimidines and triazines and their application for the treatment and / or prevention of cardiovascular diseases
EP2847152A4 (en) Compositions and methods for the treatment of metabolic syndrome
DK2583680T1 (en) Mono (PSI-7977), or combination treatment of DAA for use in the treatment of HCV
TW201300375A (en) Heterocyclic autotaxin inhibitors and uses thereof
NZ615839A (en) Novel binder-drug conjugates (adcs) and their use
MX2014008201A (en) Substituted annulated pyrimidines and triazines, and use thereof.
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
GB201106750D0 (en) Novel compounds
MX2015003406A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same.
TW201139458A (en) Methods of treating obesity using antioxidant inflammation modulators
MX2016006708A (en) Synergistic bacterial compositions and methods of production and use thereof.
EP2675469A4 (en) Compositions, devices and methods of use thereof for the treatment of cancers
MX2013008656A (en) Tetrazole compounds and methods of making and using same.
TW201343170A (en) Pharmaceutical combinations comprising a thionucleotide analog
MX357296B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections.
TW201402570A (en) Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
IL228707D0 (en) Tetrahydroquinoline derivtives useful as bromodomain inhibitors
MY158992A (en) Forms of rifaximin and uses thereof
MX346224B (en) Compostions and methods for treating chronic inflammation and inflammatory diseases.
EP2827869A4 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
MX2015006234A (en) Use of akkermansia for treating metabolic disorders.